Company Filing History:
1 out of 5 
1 out of 118 
1 out of 529 
Years Active: 2022
Title: Weiqian David Hong: Innovator in Anti-Wolbachia Compounds
Introduction
Weiqian David Hong is a notable inventor based in Liverpool, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds aimed at treating filarial worm infections.
Latest Patents
Weiqian David Hong holds a patent for "Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds." This invention relates to compounds of Formulae (I) and (II), along with their salts and solvates. The patent also encompasses pharmaceutical compositions that include these compounds and their application in the treatment or prevention of filarial worm infections, as well as other related diseases.
Career Highlights
Throughout his career, Weiqian David Hong has been associated with prestigious institutions such as the Liverpool School of Tropical Medicine and The University of Liverpool. His work has focused on innovative solutions to combat parasitic infections, showcasing his commitment to advancing medical science.
Collaborations
Weiqian has collaborated with esteemed colleagues, including Stephen Andrew Ward and Mark John Taylor. Their combined expertise has contributed to the development of effective treatments in the field of tropical medicine.
Conclusion
Weiqian David Hong's innovative work in anti-Wolbachia compounds highlights his significant role in addressing critical health challenges. His contributions continue to impact the field of pharmaceutical research and development.